Au­robindo Phar­ma’s US branch is­sues a re­call of a gener­ic med­i­cine

In­di­an gener­ics man­u­fac­tur­er Au­robindo is hav­ing to pull an­oth­er prod­uct off the shelves.

Ac­cord­ing to the FDA, the com­pa­ny’s US branch, Au­robindo Phar­ma USA, has is­sued a vol­un­tary re­call of two batch­es of the heart med­ica­tion Quinapril. The re­call was is­sued over a “Ni­trosamine Drug Sub­stance Re­lat­ed Im­pu­ri­ty” above the pro­posed lim­it.

Ni­trosamines, an or­gan­ic chem­i­cal com­mon in wa­ter or foods, can in­crease the risk of can­cer if peo­ple are ex­posed to them over an ex­tend­ed pe­ri­od. The FDA re­port­ed that Au­robindo Phar­ma USA has not re­ceived any re­ports of ad­verse ef­fects re­lat­ed to the re­call.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER